FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2980482017> ?p ?o ?g. }

• W2980482017 endingPage "7769" @default.
• W2980482017 startingPage "7763" @default.
• W2980482017 abstract "BACKGROUND:Pulmonary hypertension is a common complication of interstitial lung disease. This study was conducted to retrospectively analyze the incidence of pulmonary hypertension among interstitial lung disease patients and the correlation between systolic pulmonary artery pressure (PASP) and pulmonary functions. We also intended to investigate whether antinuclear antibody (ANA) could be an effective indicator of pulmonary hypertension. MATERIAL AND METHODS:There were 182 patients diagnosed with interstitial lung disease through high-resolution computed tomography (HRCT). Pulmonary hypertension was defined as an increase of mean pulmonary arterial pressure (PAPm) ≥25 mmHg (~PASP ≥40 mmHg) at rest. Severe pulmonary hypertension was defined as PAPm ≥35 mmHg. There were 104 cases including in this study. There were 67 cases from the ANA positive (ANA+) group and 37 cases from the ANA negative (ANA–) group. All study patients had pulmonary function tests, which included the measurements of maximal voluntary ventilation (MVV), residual volume (RV), total lung capacity (TLC), forced expiratory volume (FVC), vital capacity (VC), and diffusing capacity of the lungs for carbon monoxide (DLCO). RESULTS:The pulmonary hypertension incidence in the study cohort was 25%, and the severe pulmonary hypertension incidence was 6.48%. The incidence of pulmonary hypertension in ANA+ cases was 22.22%. The incidence of pulmonary hypertension in the ANA– cases was 32.14%. The lung function test results showed moderate relationships between DLCO, FVC%, VC%, and PASP; no relationship between MVV, FEV1/FVC%, RV/TLC, and PASP; minimum relationship between FVC%, VC%, and PASP in the ANA+ group; and moderate relationship between FVC%, VC%, and PASP in the ANA– group. CONCLUSIONS:Pulmonary hypertension occurred in 25% of the 182 interstitial lung disease patients and was negatively associated with deteriorated lung functions (specifically VC%, FVC%, and DLCO parameters). ANA level was not associated with the prognosis of pulmonary hypertension of patients with interstitial lung disease, and it did not significantly affect the correlation between PASP and pulmonary functions. Thus, ANA level did not seem to be a necessary indicator of pulmonary hypertension, and a more effective treatment method for pulmonary hypertension of patients with interstitial lung disease is urgently needed." @default.
• W2980482017 created "2019-10-25" @default.
• W2980482017 creator A5009624424 @default.
• W2980482017 creator A5014020226 @default.
• W2980482017 creator A5018392154 @default.
• W2980482017 creator A5036684349 @default.
• W2980482017 creator A5044751571 @default.
• W2980482017 date "2019-10-16" @default.
• W2980482017 modified "2023-10-15" @default.
• W2980482017 title "Clinical Retrospective Analysis of Interstitial Lung Disease Patients Associated with Pulmonary Hypertension" @default.
• W2980482017 cites W1972784084 @default.
• W2980482017 cites W1986599134 @default.
• W2980482017 cites W1996883499 @default.
• W2980482017 cites W2011870650 @default.
• W2980482017 cites W2027301488 @default.
• W2980482017 cites W2030623359 @default.
• W2980482017 cites W2037681111 @default.
• W2980482017 cites W2066138662 @default.
• W2980482017 cites W2079988825 @default.
• W2980482017 cites W2089858213 @default.
• W2980482017 cites W2098196669 @default.
• W2980482017 cites W2099543863 @default.
• W2980482017 cites W2115930642 @default.
• W2980482017 cites W2121036590 @default.
• W2980482017 cites W2123137799 @default.
• W2980482017 cites W2128026774 @default.
• W2980482017 cites W2132798299 @default.
• W2980482017 cites W2134620358 @default.
• W2980482017 cites W2135546982 @default.
• W2980482017 cites W2141016547 @default.
• W2980482017 cites W2143551777 @default.
• W2980482017 cites W2152055220 @default.
• W2980482017 cites W2152721190 @default.
• W2980482017 cites W2153328864 @default.
• W2980482017 cites W2572971719 @default.
• W2980482017 cites W2799367406 @default.
• W2980482017 cites W2953301092 @default.
• W2980482017 doi "https://doi.org/10.12659/msm.916585" @default.
• W2980482017 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6816330" @default.
• W2980482017 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31618191" @default.
• W2980482017 hasPublicationYear "2019" @default.
• W2980482017 type Work @default.
• W2980482017 sameAs 2980482017 @default.
• W2980482017 citedByCount "3" @default.
• W2980482017 countsByYear W29804820172020 @default.
• W2980482017 countsByYear W29804820172022 @default.
• W2980482017 crossrefType "journal-article" @default.
• W2980482017 hasAuthorship W2980482017A5009624424 @default.
• W2980482017 hasAuthorship W2980482017A5014020226 @default.
• W2980482017 hasAuthorship W2980482017A5018392154 @default.
• W2980482017 hasAuthorship W2980482017A5036684349 @default.
• W2980482017 hasAuthorship W2980482017A5044751571 @default.
• W2980482017 hasBestOaLocation W29804820172 @default.
• W2980482017 hasConcept C126322002 @default.
• W2980482017 hasConcept C16020263 @default.
• W2980482017 hasConcept C164705383 @default.
• W2980482017 hasConcept C165637977 @default.
• W2980482017 hasConcept C27101514 @default.
• W2980482017 hasConcept C2777543607 @default.
• W2980482017 hasConcept C2777714996 @default.
• W2980482017 hasConcept C2779619758 @default.
• W2980482017 hasConcept C2780930700 @default.
• W2980482017 hasConcept C2780940725 @default.
• W2980482017 hasConcept C3018587741 @default.
• W2980482017 hasConcept C55520419 @default.
• W2980482017 hasConcept C71924100 @default.
• W2980482017 hasConcept C75603125 @default.
• W2980482017 hasConceptScore W2980482017C126322002 @default.
• W2980482017 hasConceptScore W2980482017C16020263 @default.
• W2980482017 hasConceptScore W2980482017C164705383 @default.
• W2980482017 hasConceptScore W2980482017C165637977 @default.
• W2980482017 hasConceptScore W2980482017C27101514 @default.
• W2980482017 hasConceptScore W2980482017C2777543607 @default.
• W2980482017 hasConceptScore W2980482017C2777714996 @default.
• W2980482017 hasConceptScore W2980482017C2779619758 @default.
• W2980482017 hasConceptScore W2980482017C2780930700 @default.
• W2980482017 hasConceptScore W2980482017C2780940725 @default.
• W2980482017 hasConceptScore W2980482017C3018587741 @default.
• W2980482017 hasConceptScore W2980482017C55520419 @default.
• W2980482017 hasConceptScore W2980482017C71924100 @default.
• W2980482017 hasConceptScore W2980482017C75603125 @default.
• W2980482017 hasLocation W29804820171 @default.
• W2980482017 hasLocation W29804820172 @default.
• W2980482017 hasLocation W29804820173 @default.
• W2980482017 hasLocation W29804820174 @default.
• W2980482017 hasOpenAccess W2980482017 @default.
• W2980482017 hasPrimaryLocation W29804820171 @default.
• W2980482017 hasRelatedWork W1632012575 @default.
• W2980482017 hasRelatedWork W2097837155 @default.
• W2980482017 hasRelatedWork W2210188716 @default.
• W2980482017 hasRelatedWork W2339555669 @default.
• W2980482017 hasRelatedWork W2346794405 @default.
• W2980482017 hasRelatedWork W2589196410 @default.
• W2980482017 hasRelatedWork W2736661988 @default.
• W2980482017 hasRelatedWork W3097530996 @default.
• W2980482017 hasRelatedWork W4291061 @default.
• W2980482017 hasRelatedWork W9675542 @default.
• W2980482017 hasVolume "25" @default.

• next